New to this clinic?
We want to ensure you have all the information you need for parking at our new clinic at 110 E. Court Ave., Ste. 200 in downtown Des Moines.
Location hours
Open
- Sunday:
- Closed
- Monday:
- 8:00 am - 5:00 pm
- Tuesday:
- 8:00 am - 5:00 pm
- Wednesday:
- 8:00 am - 5:00 pm
- Thursday:
- 8:00 am - 5:00 pm
- Friday:
- 8:00 am - 5:00 pm
- Saturday:
- Closed
41.5868469, -93.6149914
Services at this location
Show more
Clinics and amenities at this location
Select office type
Providers at Des Moines, E. Court Ave
Need help selecting a provider?
When you call 1-515-282-2921 we'll help you find a provider who meets your needs.
Clinical Trials
Mission Cancer + Blood offers a variety of cancer clinical trials at our Des Moines, E. Court Ave location.
Patient Stories
March 18, 2026
January 5, 2026
Educational Resources
Awards and Recognition
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - No. 1 in Iowa for Cancer Care
We are proudly ranked No. 1 in Iowa for Cancer Care in the 2026–27 “Adult, Best Hospitals” report.
Utilization Review Accreditation Commission (URAC) Accreditation
UI Health Care, on behalf of its Ambulatory Care Pharmacy, has received the Specialty Pharmacy 4.0 Rare Disease Pharmacy Center of Excellence Designation.
Gold Seal - Joint Commission on the Accreditation
UI Health Care Specialty Pharmacy has the gold seal of approval for a specialty pharmacy from the Joint Commission.
U.S. News & World Report - Leukemia
In 2026-27 our leukemia program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Lymphoma
In 2026-27 our lymphoma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Myeloma
In 2026-27 our myeloma program was identified as High Performing by U.S. News & World Report.
U.S. News & World Report - Colon cancer surgery, lung cancer surgery, and prostate cancer surgery
In 2026-27 our colon cancer surgery, lung cancer surgery, and prostate cancer surgery programs were identified as High Performing by U.S. News & World Report.